Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Reviva Pharmaceuticals Holdings (RVPH)
NASDAQ:RVPH
RESEARCH TOOLSreports
Reviva Pharmaceuticals Holdings (RVPH) Stock Forecast & Price Target
151 Followers
See the Price Targets and Ratings of:
RVPH Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
RVPH Stock 12 Month Forecast
Average Price Target
$20.00
▲(500.60% Upside)
| Highest Price Target$20.00 | Average Price Target$20.00 | Lowest Price Target$20.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
H.C. Wainwright
Reiterated
03/25/24
Alliance Global Partners
$12.00
Buy
260.36%
Upside
Reiterated
10/30/23
Reviva data robust across multiple endpoints, says Roth MKMReviva data robust across multiple endpoints, says Roth MKM
Maxim Group
$18.00
Buy
440.54%
Upside
Reiterated
10/30/23
Analysts Offer Insights on Healthcare Companies: Reviva Pharmaceuticals Holdings (NASDAQ: RVPH) and SeaStar Medical Holding (NASDAQ: ICU)
Benchmark Co.
$17.00
Buy
410.51%
Upside
Initiated
06/08/23
Reviva Pharmaceuticals initiated with a Speculative Buy at BenchmarkReviva Pharmaceuticals initiated with a Speculative Buy at Benchmark
RVPH Analyst Recommendation Trends
Rating
Oct 23
Dec 23
Jan 24
Feb 24
Mar 24
Strong Buy
8
8
6
4
3
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
8
6
4
3
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
RVPH Financial Forecast
RVPH Stock Forecast FAQ
What is RVPH’s average 12-month price target, according to analysts?
Based on analyst ratings, Reviva Pharmaceuticals Holdings’s 12-month average price target is $20.00.
What is RVPH’s upside potential, based on the analysts’ average price target?
Reviva Pharmaceuticals Holdings has 500.60% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is RVPH a Buy, Sell or Hold?
Reviva Pharmaceuticals Holdings has a conensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Reviva Pharmaceuticals Holdings’s price target?
The average price target for Reviva Pharmaceuticals Holdings is $20.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $20.00 ,the lowest forecast is $20.00. The average price target represents 500.60% Increase from the current price of $3.33.
The highest analyst price target is $20.00 ,the lowest forecast is $20.00. The average price target represents 500.60% Increase from the current price of $3.33.
What do analysts say about Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of RVPH?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.